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Recently, it was suggested that β-aminoisobutyric acid (BAIBA) is a myokine involved in
browning of fat. However, there is no evidence for an acute effect of exercise supporting
this statement and the metabolic distinct enantiomers of BAIBA were not taken into
account. Concerning these enantiomers, there is at this point no consensus about
resting concentrations of plasma R- and S-BAIBA. Additionally, a polymorphism of
the alanine - glyoxylate aminotransferase 2 (AGXT2) gene (rs37369) is known to have
a high impact on baseline levels of total BAIBA, but the effect on the enantiomers
is unknown. Fifteen healthy recreationally active subjects, with different genotypes of
rs37369, participated in a randomized crossover trial where they exercised for 1 h at
40% of Ppeak or remained at rest. Plasma samples were analyzed for R- and S-BAIBA
using dual column HPLC-fluorescence. The plasma concentration of baseline R-BAIBA
was 67 times higher compared to S-BAIBA (1734 ± 821 vs. 29.3 ± 7.8 nM). Exercise
induced a 13 and 20% increase in R-BAIBA and S-BAIBA, respectively. The AGXT2
rs37369 genotype strongly affected baseline levels of R-BAIBA, but did not have an
impact on baseline S-BAIBA. We demonstrate that BAIBA should not be treated as
one molecule, given (1) the markedly uneven distribution of its enantiomers in human
plasma favoring R-BAIBA, and (2) their different metabolic source, as evidenced by the
AGXT2 polymorphism only affecting R-BAIBA. The proposed function in organ cross
talk is supported by the current data and may apply to both enantiomers, but the tissue
of origin remains unclear.
Keywords: myokine, exerkine, BAIBA, 3-amino-2-methylpropanoic acid, AGXT2
INTRODUCTION
β-aminoisobutyric acid (BAIBA), also known as 3-amino-2-methylpropanoic acid, is a non-
proteinogenic amino acid. It is a known catabolite of thymine and valine metabolism in mammals.
Roberts et al. (2014) recently proposed that, although BAIBA is not a peptide or a protein, it might
also be a myokine (Roberts et al., 2014), i.e., “a cytokine or other peptide, produced, expressed and
released by muscle fibers and exerting either paracrine or endocrine effects” (Pedersen et al., 2007).
First, Roberts and coworkers (Roberts et al., 2014) showed that BAIBA was secreted by myocytes
Abbreviations: AGXT2, alanine - glyoxylate aminotransferase 2; BAIBA, β-aminoisobutyric acid; BCAA, brached chain
amino acids; GABA-T, 4-aminobutyrate-2-oxoglutarate transaminase; MMSA, methylmalonate semialdehyde.
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overexpressing the exercise-induced transcription factor
PGC-1α. Second, they established that after 3 weeks, plasma
BAIBA concentration increased by 20% in mice having access
to a running wheel compared to their sedentary littermates. In
humans, a chronic elevation of 17% was observed following
20 weeks (3 days/week) of aerobic exercise in previously
sedentary and healthy subjects. However, potential acute
changes of plasma BAIBA in response to exercise, which is
a common characteristic of myokines, were not investigated
by these authors at that point. Third, it was suggested that
enhanced plasma BAIBA concentrations could have systemic
functions. This statement is supported by these and several
other investigators who found systemic effects of BAIBA
supplementation as reviewed by Tanianskii et al. (2019). For
example in mice, supplementation of BAIBA increased the
expression of brown adipocyte-specific genes in white adipose
tissue and increased the hepatic β-oxidation through a PPARα
mediated metabolism (Roberts et al., 2014). Exogenous BAIBA
supplementation also led to a decrease in body fat in mice.
Finally, the authors suggesting that BAIBA is a myokine found
that, in humans, BAIBA levels were inversely correlated to
cardiometabolic risk factors (Roberts et al., 2014). Based upon all
information available it was therefore hypothesized by different
authors that muscle-derived BAIBA could be a mechanistic
component of the well-established beneficial effects of physical
exercise in chronic metabolic diseases (Ginter and Simko, 2014;
Kammoun and Febbraio, 2014). Unfortunately, independent
investigators have not yet confirmed this hypothesis in humans.
In contrast, Morales et al. (2017) did not find acute changes in
plasma BAIBA concentrations following a 350 kcal exercise at
70% of VO2peak (Morales et al., 2017). Altogether, there is at
this moment no evidence for an acute exercise-mediated effect
on plasma BAIBA.
Interestingly, BAIBA has a chiral center and therefore it has
two enantiomers: R-BAIBA and S-BAIBA. While very little is
known about the physiological role of BAIBA, even less is known
about the potential difference in physiological behavior of its
enantiomers. R-BAIBA is derived from thymine in three steps
that take place in the cytosol of primarily liver and kidney
cells (Figure 1; Van Kuilenburg et al., 2006). Subsequently,
R-BAIBA can be further metabolized by the transaminase
AGXT2 (EC 2.6.1.44) into R-methylmalonate semialdehyde
(MMSA) in the mitochondria (Rodionov et al., 2014). On the
other hand, S-BAIBA is derived from valine in the mitochondria
of primarily skeletal muscle (Brosnan and Brosnan, 2006).
S-BAIBA is both formed and degraded by GABA-T (EC 2.6.1.19)
via the metabolite S-MMSA. Both R- and S-MMSA can be
metabolized into propionyl-CoA and further metabolized into
the tricarboxylic acid cycle. Although it has been suggested, there
is at this point no solid evidence for a spontaneous or enzymatic
racemization that might be able to convert R-/S- BAIBA directly
or via R-/S- MMSA in healthy humans (Van Gennip et al.,
1981; Tamaki et al., 1990; Roe et al., 1998). Despite its known
distinct metabolism, the physiological function of the BAIBA
enantiomers has not been studied separately, until recently.
Kitase et al. (2018) showed that S- and not R-BAIBA was able
to protect osteocytes from cell death induced by oxidative stress
FIGURE 1 | Metabolic pathways involved in R- and S-BAIBA. Dotted lines
represent multiple enzymes. AGXT2: alanine glyoxylate aminotransferase 2
(EC 2.6.1.44). GABA-T: 4-aminobutyrate transaminase (EC 2.6.1.19). rs37369
affects AGXT2 activity. Adapted from Van Kuilenburg et al. (2004).
(Kitase et al., 2018). Additionally S- and not R-BAIBA was
secreted from extensor digitorum longus and soleus in a mouse
ex vivo contractility protocol (Kitase et al., 2018).
In plasma, the concentration of the total amount of BAIBA
is reported to be in the low µM range (Van Kuilenburg et al.,
2004), whereas urinary concentrations have been reported in
a very broad range (Gartler, 1956). The large inter-individual
variability of BAIBA in urine relates to the presence of the so-
called hyper-BAIBA trait in some individuals. This autosomal
recessive trait causes urinary BAIBA levels to increase 100-fold
compared to normal concentrations. Hyper-BAIBA excretion has
been linked to different single nucleotide polymorphisms (SNPs)
in the AGXT2 gene (Nicholson et al., 2011; Seppala et al., 2014;
Yoshino et al., 2014) that decimate the enzyme activity (Kittel
et al., 2013). The relation between BAIBA and SNP rs37369 has
been identified in a genome wide association study as the most
deterministic SNP explaining the concentration of BAIBA in
urine (Suhre et al., 2011). Additionally, the 1000 genomes project
shows that rs37369 TT genotype, associated with low activity, has
the highest prevalence of all AGXT2 SNPs with marked difference
between African and East Asian populations (>30%) compared
to Caucasian (<1%) (The 1000 Genomes Project Consortium,
2015). A conceivable possibility would be that the rs37369 SNP
induces altered metabolism and accumulation of only R-BAIBA,
as AGXT2 is not involved in the S-BAIBA metabolism. In urine,
the amount of R-BAIBA is more than 95% of total BAIBA (Solem
et al., 1974), while the relative contribution of R- and S-BAIBA
to the total amount of BAIBA in plasma is still in debate. Some
authors reported that R-BAIBA was 20% (Solem et al., 1974),
while others reported it to be 53% (Gejyo et al., 1976).
The first aim of this study is to elucidate the baseline
concentrations and ratio of both enantiomers in plasma and
urine. In addition, this study investigates whether or not an
exercise-induced plasma increase of R- vs. S-BAIBA occurs.
Third, individuals with the TT genotype for SNP rs37369 provide
a healthy human AGXT2 knock-down model making it possible
to determine whether this enzyme is indeed only involved in
the homeostatic control of R-BAIBA, and not S-BAIBA. The
latter would provide evidence for separate BAIBA enantiomer
metabolism in humans.
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MATERIALS AND METHODS
Subjects
In a first phase, 322 Caucasian subjects were genotyped for
rs37369. Fifteen healthy recreationally active male (n = 12)
and female (n = 3) subjects (age: 23.5 ± 3.4 year, body mass:
74.6 ± 12.7 kg, height 180.1 ± 7.4 cm) were included in the
study. Hereof 3 TT [homozygous for minor allele; associated
with low AGXT2 activity (Kittel et al., 2014; The 1000 Genomes
Project Consortium, 2015)], 7 CC [homozygous for major allele;
associated with normal AGXT2 activity (Kittel et al., 2014; The
1000 Genomes Project Consortium, 2015)] and 5 (heterozygous)
participants matched for sex, body mass, body height, and
activity/fitness level were recruited. Written informed consent
to participate in the randomized cross-over interventional study
was obtained from all participants conform the Declaration of
Helsinki and the study was approved by the Ghent University
Hospital Ethical Committee.
Screening
DNA was isolated from fresh whole venous blood (EDTA coated
vacutainer) with Gentra Puregene Blood Core Kit according
to manufacturer’s instructions with minor adaptations (Qiagen,
Hilden, Germany), prelevated from an antecubital vein at rest.
Incubation time with RBC lysis and cell lysis solution was
increased from, respectively, 10 min to 1 h and 0 min to
2 h. Based on the A260/A280 ratio, DNA quality (1.8–2)
and DNA concentrations was assessed using the nanodrop
2000C spectrophotometer (Thermo scientific, Wilmington, MA,
United States). Rs37369 genotyping using high resolution
melting (HRM) was performed based on Sutter et al. (2013).
In short, PCR and HRM was carried out on a LightCycler 480
system (Roche, Penzberg, Germany) using a 8.1 µl reaction
mix containing 0.5 µl DNA (25 ng.µl−1), 0.4 µL primermix
(4 µM), 6 µl JumpStartTM Taq Readymix with MgCl2 (Merck
Life Science, Darmstadt, Germany) and 1.2 µl SYBR Green PCR
Master Mix (Applied Biosystems, Foster city, CA, United States).
Analysis was performed under the following parameters: pre-
incubation: 95◦C for 3 min. Amplification/quantification: 30 s
at 95◦C, 30 s at 58◦C and 1 min at 72◦C. Melting curve: 1 min
at 95◦C, 1 min at 40◦C, 1 s at 65◦C, ramp rate 0.02◦C.s−1 up
to 90◦C; 25 acquisitions per ◦C. Using LightCycler 480 Gene
scanning software (vs. 1.5.1) the normalized and shifted melting
curves were analyzed.
Forward and reverse primer (CAT TGG AGG GTG GAA
GAA GA and CAG AAA GGT GAA TGC AGT GG) were
designed using Primer3plus software. Both primers are 20 base
pairs in length. The primer melting temperature is respectively,
60.0 and 59.3, whereas the product size is 79 base pairs.
Study Design – Blood and Urine
Sampling
The experiment consisted of three experimental test days. On the
first test day, following a medical screening, subjects performed
an incremental cycling test (50 Watt for 3 min+ 25 Watt.min−1;
Lode Excalibur Sport, Groningen, Netherlands) during which gas
exchange was measured (breath-by-breath; Jaeger Oxycon Pro,
Viasys Healthcare GmbH, Höchberg, Germany). Participants
were instructed to keep their cadence between 70 and 80 rpm,
and strong verbal encouragement was provided throughout the
test to ensure maximum effort. The protocol was terminated
at voluntary exhaustion, which was defined as the inability to
maintain a minimal cadence of 70 rpm for more than five
consecutive seconds. Heart rate (HR) was monitored on a
continuous basis (H7 Sensor; Polar, Kempele, Finland). Based
upon this incremental test, maximal power output (Ppeak) and
VO2Peak were determined. Breath-by-breath VO2 data were
transformed into 10-s values for further analysis, and VO2Peak
was defined as the highest 30-s average achieved during the test.
On the other test days, subjects returned fasted and by passive
transport to the lab. At arrival, a catheter was inserted in an
antecubital vein and subjects were asked to empty their bladder,
but urine was not yet collected. Subsequently, during a 20 min
period, subjects ate breakfast (ingredients that could be chosen:
white bread, jam, chocolate paste, cheese, banana), and kept
record of what and how much they ate. Subjects could drink
water at libitum. One hour after the start of the breakfast subjects
started cycling at 40% of their Ppeak or remained at rest (test
day exercise or rest). Subjects were randomly assigned to first
perform either the exercise or the rest test day. At test day
“exercise”, subjects were instructed to cycle on an ergometer
(Lode Excalibur Sport, Groningen, Netherlands) for 1 h at a
cadence of their choice and every 15 min rate of perceived
exertion (RPE) was evaluated using a 10 point borg scale. Ten
min before the exercise, subjects were instructed to empty their
bladder for urine sampling. An aliquot was kept at −20◦C. Just
before (0’), after 30 and 60 min of cycling and 30 (90’) min
following the exercise, blood was obtained via the catheter. Blood
was withdrawn using heparin coated vacutainers (Vacutest Kima,
Italy), centrifuged at 11000 g (centrifuge 5702 R, Eppendorf) and
the plasma was stored at −20◦C before further analysis. During
the whole test subjects were allowed to drink water at libitum. At
test day “rest” food intake, blood and urine sampling was kept
identical. The first, second and third test day were each separated
by at least 1 week.
The exercise intensity of the 1-h exercise was chosen based on
evidence that aerobic exercise, such as the 1-h exercise at 40%
Ppeak (Bex et al., 2015), is known to activate PGC1-α (Russell
et al., 2003) and that aerobic exercise and PGC1-α are known to
modulate BAIBA (Roberts et al., 2014).
Plasma and Urinary S- and R-BAIBA
Determination
Urine and plasma samples (200 µl) were deproteinized by
thoroughly mixing with 20 µl of 5 and 35% (w/v) sulphosalicylic
acid, respectively, and samples were stored at 4
◦
C for 30 min.
After centrifugation (11000 g, 10 min), 150 µl of urine and
plasma supernatants were collected and mixed with 150 µl
of lithium citrate buffer pH 2.2 (Biochrom, United Kingdom).
Urine samples were further diluted 1:10 with the same lithium
citrate buffer before putting the vials in a Gilson autosampler.
S- and R-BAIBA were detected in plasma and urine samples with
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fluorescence detection of orthophthaldialdehyde-N-isobutyryl-
L-cysteine derivatives of S- and R-BAIBA after separation with
dual-column reversed-phase HPLC, essentially as described
before (Brückner et al., 1995). Thirty five µl OPA (30 mM) –
IBLC (45 mM) in a 0.8 M K- borate buffer was added to
70 µl sample by the autosampler, this solution was mixed by
three times up and down pipetting, before 80 µl was added
to a reaction vial. Following an incubation time of 30 s 50 µl
was injected to column I (SUPELCOSILTM LC-18-DB). Solvent
A used for chromatography on column I consisted of 0.17 M
Sodium acetate and 16.7% acetonitrile (pH 5), while solvent
B consisted of 90.9% Methanol. The compounds of interest
eluting from column I were introduced to column II (Altima
C18) between minute 14–20 and elution was performed with
0.1 M sodium acetate and 26% acetonitrile (pH 4.8) with a
flow of 1 ml.min−1. Fluorescence detection was performed
using an excitation and emission wavelength of 330 nm and
450 nm, respectively. For plasma, the limit of quantification was
0.02 µM for R- and S-BAIBA. The within-run variability for
concentrations similar to those observed in this study was <5%,
while the between run variability was about 6% for R-BAIBA
and 16% for S-BAIBA. Recovery was 104.9 ± 6.6% R- and
107.0 ± 5.1% for S- BAIBA. For urine, the limit of quantification
was 0.05 µM for R- and S-BAIBA. The within-run variability
was 7 and 8% for R- and S-BAIBA, respectively, while the
between run variability was about 8% for R-BAIBA and 9% for
S-BAIBA. Recovery was 99.4± 6.2 and 95.7± 3.7% for R- and S-
BAIBA, respectively.
Albumin and Creatine Kinase
Determination
Albumin and Creatine Kinase (CK) were determined in serum
samples using a commercially available Roche Cobas system at a
clinical laboratory.
Statistics
All quantitative variables were tested for normality using a
Shapiro–Wilk test. S-BAIBA was normally distributed in plasma
and urine. In contrast, circulating and urinary R-BAIBA did
not have a normal distribution. Kruskal Wallis test, followed by
Mann–Whitney test was performed to compare the difference
in baseline values (age; body weight; length; Ppeak; VO2peak,
R- and S-BAIBA) between the three genotypes. To investigate
the effect of exercise on R- and S-BAIBA concentrations in
plasma a multivariate 2 × 4 repeated-measures MANOVA was
used with “condition” (cycling, rest) and “time” (0′, 30′, 60′,
and 90′) as within-subjects factors and R- and S-BAIBA as
different measures. Consecutively, pairwise comparisons were
used to compare the different time points. When the variable
of interest was not normally distributed a Wilcoxon test was
performed. In order to investigate the influence of the AGXT2
genotype on plasma R- and S-BAIBA kinetics a multivariate
3 × 2 × 4 repeated-measures ANOVA was used with “genotype”
(TT, CT, CC) as a between-subjects factor and “condition”
(cycling, rest) and “time” (0′, 30′, 60′, and 90′) as within-
subjects factor. Spearman and Pearson correlations were run
with variables that were, respectively, normally or not-normally
distributed. All statistical analyses were performed using the
Statistical Package for the Social Sciences (version 23.0; SPSS,
Chicago, IL, United States). Values are presented as mean ± SD
and significance was assumed at P < 0.05.
RESULTS
The anthropometric and physical characteristics were not
significantly different between the three groups with different
AGXT2 genotypes (CC, CT, TT) (Table 1). The mean
(± SD) VO2peak and Ppeak were 50.2 ± 10.2 ml/kg/min and
347 ± 74 Watt, respectively. The actual 1-h aerobic exercise test
was performed at 139± 30 Watt, which corresponded to 62± 9%
of VO2peak and was below each participant’s aerobic threshold,
as evaluated with the gas exchange threshold. RPE of the exercise
ranged from 3 (moderate) to 5 (hard).
Baseline R- and S-BAIBA
R-BAIBA was by far the most predominant enantiomer
in both plasma and urine. The mean concentration
of baseline R-BAIBA was 66.7 times higher in plasma
(1734± 821 nM vs 29.3± 7.8 nM) and 334 times higher in urine
(35160 ± 47026 µmol/mol creatinine vs 90.4 ± 47.0 µmol/mol
creatinine) than S-BAIBA. Plasma S-BAIBA was only
2.03 ± 0.99% of the total amount of BAIBA, whereas urinary
S-BAIBA accounted for 1.18 ± 1.43%. The amount of baseline
R-BAIBA was not correlated to the amount of baseline S-BAIBA
in plasma nor in urine (plasma r = −0.333; p = 0.225, urine
r = 0.116; p = 0.705). Additionally, there was no intra-individual
difference in baseline plasma and urine R- (p = 0.588; p = 0.334)
and S-BAIBA (p = 0.356; p = 0.881) between test days.
Baseline plasma R-BAIBA was higher in subjects with TT
genotype compared to heterozygous (p = 0.025) and homozygous
CC (p = 0.017) subjects (Figure 2A). R-BAIBA was only trend
higher (p = 0.062) in subjects with CT compared to CC
subjects. In contrast, rs37369 had no effect on plasma S-BAIBA
levels (Figure 2B). Similarly, rs37369 strongly affected urinary
R-BAIBA (p = 0.013), but not S-BAIBA levels (Figures 2C,D).
Interestingly, Ppeak and VO2peak were positively correlated to
baseline concentrations of plasma S-BAIBA (Table 2).
Effect of Exercise
One hour of exercise at 40% of Ppeak evoked an increase
of circulating R-BAIBA compared to remaining in rest
(condition∗time p < 0.001) (Figure 3A). There was an increase
after 30 min (+ 6%; p = 0.012) and an additional increase
after 60 min (+13% compared to baseline, p = 0.001) of exercise
(Figure 3B). During recovery, R-BAIBA returned to levels similar
to levels after 30 min (+6% compared to baseline, p = 0.035). On
the rest day, a slight decrease in plasma R-BAIBA was observed
after 60 and 90 min (p = 0.05). R-BAIBA concentrations were
significantly higher on the cycling day compared to the rest day
at 60 min (p < 0.001) and 90 min (p = 0.003). In the rs37369
TT genotype, R-BAIBA concentrations were higher (main effect
of genotype; p < 0.001), but the exercise-induced kinetics were
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TABLE 1 | Baseline characteristics.
CC CT TT mean
Total n 7 5 3 15
Age (year) 22.3 ± 1.1 25.2 ± 5.5 23.7 ± 2.3 23.5 ± 3.4
Body weight (kg) 74.7 ± 9.6 71.3 ± 10.5 79.7 ± 23.6 74.6 ± 12.7
Height (cm) 183 ± 7 175 ± 8 182 ± 6 180 ± 7
VO2peak (ml.kg−1.min−1) 51.9 ± 6.1 48.7 ± 16.2 48.5 ± 8.8 50.2 ± 10.2
40% Ppeak (Watt) 146 ± 27 127 ± 37 140 ± 26 139 ± 30
Female n 1 1 1 3
Age (year) 22.8 24.9 21 22.9 ± 1.9
Body weight (kg) 63.2 58.8 57.4 59.8 ± 3
Height (cm) 174 171 176 173 ± 3
VO2peak (ml.kg−1.min−1) 38.7 35 48 40.6 ± 6.7
40% Ppeak (Watt) 93 80 110 94.3 ± 15
Male n 6 4 2 12
Age (year) 22.3 ± 1.2 25.2 ± 6.3 25.0 ± 0.3 23.7 ± 3.7
Body weight (kg) 76.7 ± 8.9 74.4 ± 9.0 90.8 ± 19.2 78.3 ± 11.3
Height (cm) 184 ± 6 176 ± 9 186 ± 4 182 ± 7
VO2peak (ml.kg−1.min−1) 54.1 ± 2.0 52.2 ± 16.5 48.7 ± 12.4 52.6 ± 9.7
40% Ppeak (Watt) 155 ± 15 139 ± 31 155 ± 0 150 ± 20
Values are presented as mean ± SD, no differences between genotypes.
FIGURE 2 | Baseline S- and R-BAIBA concentrations. Individual baseline levels of plasma R- and S-BAIBA (A,B) and urinary R- and S-BAIBA (C,D) concentrations
separated for rs37369 genotype. Cross represents the mean. ∗P < 0.05.
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TABLE 2 | Correlations S-BAIBA.
Baseline S-BAIBA Increase of S-BAIBA
From 0′–90′
Age r −0.159 −0.354
p 0.571 0.195
BMI r 0.150 0.074
p 0.593 0.794
Ppeak r 0.745 0.462
p 0.001∗ 0.083$
VO2peak r 0.760 0.564
p 0.001∗ 0.029∗
∗p < 0.050, $0.05 < p < 0.10.
not significantly affected by genotype (condition∗time∗genotype
p = 0.503) (Figure 3C).
During exercise, the plasma kinetics of S-BAIBA were
significantly different from the rest day (condition∗time
p < 0.001) (Figure 4A). There was an increase of S-BAIBA
from baseline to 30 min (+10%; p = 0.007) and 60 min of
exercise (+20%; p < 0.001 compared to baseline), whereafter
S-BAIBA concentrations remained elevated during recovery
(+23%; p< 0.001 compared to baseline) (Figure 4B). At the rest
day, there was an increase of 9% after 30 min (p = 0.023) that
did not change over the following hour. Although there was a
significant interaction effect, there was no significant difference
between the absolute concentrations of S-BAIBA at any time
point between the two conditions. Genotype had no effect on
the S-BAIBA kinetics (condition∗time∗genotype p = 0.398; main
effect genotype p = 0.166). The increase of S-BAIBA after the
exercise and the 30 min recovery was significantly positively
correlated to VO2peak (Table 2).
Markers of Hemoconcentration and
Muscle Damage
We measured plasma albumin levels in order to exclude
that the observed exercise-induced changes were evoked by
hemoconcentration (Alis et al., 2015). Albumin levels remained
constant during both rest and exercise days (condition∗time:
p = 0.263) (Table 3). In order to investigate if muscle damage
occurred during exercise, the plasma concentration of CK was
determined (Brancaccio et al., 2010). During and after cycling CK
remained constant suggesting that our intervention did not cause
muscle damage (condition∗time: p = 0.994) (Table 3).
FIGURE 3 | R-BAIBA kinetics during exercise. Plasma R-BAIBA kinetics are shown for (A) the actual concentrations, (B) the delta change over time and (C) the
actual concentrations of the different groups based on rs37369 genotype. Full lines represent cycling condition and dotted lines represent resting condition. Exercise
was performed from 0 up to 60 min on test day cycling. (A,B) show mean ± SD, (C) only mean. Different letter indicates a significant difference from other time points
during cycling (Arabic) or rest (Arabic capital). ∗P < 0.05 comparison cycling and rest at same time point. Percentage differences are calculated from baseline levels.
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FIGURE 4 | S-BAIBA kinetics during exercise. Plasma S-BAIBA kinetics are shown for (A) the actual concentrations and (B) the delta change over time. Full lines
represent cycling condition and the dotted lines represent resting condition. Exercise was performed from 0 up to 60 min on test day cycling. Figures show
mean ± SD. Different letter indicates a significant difference from other time points during cycling (Arabic) or rest (Arabic capital). Percentage differences are
calculated from baseline levels.
TABLE 3 | Markers of hemoconcentration and muscle damage before during and following a 1-h aerobic exercise.
Cycling Rest
0′ 30′ 60′ 90′ 0′ 30′ 60′ 90′
Albumin (g.l−1) 49.3 ± 3.3 49.1 ± 5.8 48.3 ± 4.4 47.1 ± 4.4 47.5 ± 3.2 47.5 ± 5.3 46.3 ± 4 47.5 ± 4.7
Creatine kinase (U.l−1) 120.5 ± 57.4 119.8 ± 61.1 117.7 ± 57.9 117.5 ± 57.4 99.6 ± 34 99 ± 38.8 96.1 ± 34.4 96.9 ± 31.8
Mean ± SD are shown.
DISCUSSION
A first aim of this study was to elucidate the ratio and homeostatic
concentrations of both BAIBA enantiomers. In this study, the
plasma concentrations of R-and S-BAIBA ranged from 770 to
4120 nM and from 14 to 61 nM, respectively. This means
that “total” BAIBA was about 794 to 4147 nM, which is in
agreement with earlier studies (Armstrong, 1963). We found
that the total amount of BAIBA in plasma actually consists of
98% R-BAIBA and only 2% S-BAIBA. This is markedly different
from the 20% (Solem et al., 1974) and 53% R-BAIBA (Gejyo
et al., 1976) that has been suggested earlier. On the other
hand, the urinary “total” BAIBA concentrations reported in this
study well resembles the concentrations that have been reported
previously (Suhre et al., 2011). Also the relative proportion of
urinary R-BAIBA is about 99%, which is comparable to earlier
reports (Solem et al., 1974). Here we show that the ratio of
the enantiomers is not different between plasma and urine,
contradicting literature suggesting a difference in renal clearance
for R- and S-BAIBA (Solem et al., 1974). It is hard to speculate
why there is such high discrepancy in the ratio of enantiomers
in plasma between the present and the former studies. Gejyo
et al. (1976) suggested that difference in origin (East Asian
compared to European) might have been responsible, but this
cannot explain the difference between our current result and
the investigation of Solem et al. (1974). However, Solem et al.
(1974) only used one pooled sample from 2 persons for their
experiment. The current method has been successfully used
and therefore validated in a clinical setting in the screening
and follow-up of patients with pyrimidine degradation defect,
which strengthens our confidence in the current method.
However, due to current discrepancy in literature, independent
confirmation is preferable.
The imbalance between the BAIBA enantiomers suggests
that their metabolic pathways and sources could be separate
and unrelated. A useful approach in this respect is to explore
whether a polymorphism that affects AGXT2 activity would only
affect R-BAIBA as can be derived from the proposed metabolic
pathways (Figure 1). Indeed, we confirm that a deficient AGXT2
enzyme (TT genotype for rs37369), leading to the hyper-BAIBA
trait (Suhre et al., 2011), only affects R-BAIBA but not S-BAIBA
levels, in both plasma and urine. Although we recruited only
three TT-subjects (due to the very low prevalence of this genotype
in our Caucasian population), we believe these conclusions are
valid, since the effect size is large and non-parametric statistical
analysis was performed to account for the low sample size.
Moreover, the CT subjects seemed to be stepwise intermediate
to the TT and the CC group for R-BAIBA, but not S-BAIBA.
Therefore, the current results indicate that in healthy humans
the metabolic pathways of R- and S-BAIBA are most likely
unrelated, and that they should be investigated as separate
physiological entities.
The second aim of this study was to elucidate whether
or not an acute exercise response of R- and S-BAIBA exists.
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Following 30 min of cycling, an increase of R-BAIBA
was already observed. This increase is, although moderate,
significant. Not only R-BAIBA, but also circulating S-BAIBA
gradually increased during exercise by about 20%. Although
this absolute and relative increase is small, it is statistically
significant and suggests an exercise-related metabolism.
We demonstrate that the acute changes observed in this
investigation reflect true changes and are not caused by
exercise-induced hemoconcentration, as illustrated by the
albumin measurements.
Only two investigations have been published about the effect
of exercise on BAIBA levels in humans (Roberts et al., 2014;
Morales et al., 2017). The percentage changes in “total” BAIBA
measured in this investigation are in the same order of magnitude
as was observed by the chronic intervention in mice and humans
reported by Roberts et al. (2014). Unfortunately, these authors
did not report the absolute concentrations making it difficult
to compare with the current investigation. Additionally, it is
unknown whether the 17% increase of “total” BAIBA, was
primarily caused by R-BAIBA or S-BAIBA. We now demonstrate
that R-BAIBA is responsible for 97.8% of the 252 nM increase
in total BAIBA after 60 min acute exercise, and it could
be hypothesized that the same holds true for the observed
chronic effects (Roberts et al., 2014). Our results are not in
congruence with Morales et al. (2017) who did not find an
increase of BAIBA following a 350 kcal acute exercise at 70%
VO2peak, lasting about 30 min. This difference in results
could be due to differences in study design. In contrast to
our study, they did not perform a crossover design where the
subjects did not exercise. Additionally, we observed the highest
effects after 60 min of exercise, whereas their exercise had a
shorter duration.
The current investigation does not provide evidence for
the origin of R- and S-BAIBA in the circulation. Either this
can be released from an endogenous storage or it could be
acutely formed. Based on the current literature it cannot be
excluded that part of the increase is caused by previously stored
R- or S-BAIBA. “Total” BAIBA has been detected, but not
quantified in mice (Roberts et al., 2014; Hatazawa et al., 2015)
and human (Fazelzadeh et al., 2016) muscle, but information
of the single enantiomers is lacking. On the other hand, there
is evidence toward acute production of both enantiomers as
well. The acute increase of R-BAIBA could possibly be explained
by a higher pyrimidine turnover during exercise, although
this suggestion is based upon measurement of only uridine
and not thymine (Yamamoto et al., 1997). Since there is only
limited evidence for thymine degradation during exercise at
present, R-BAIBA might be used as a marker as proposed by
Solem et al. (1974). Interestingly, acutely formed R-BAIBA is
most likely not muscle derived as thymine degradation activity
is very low in muscle compared to liver and kidney (Van
Kuilenburg et al., 2006), implying that acutely formed R-BAIBA
might be an exerkine, an exercise induced factor released from
any organ during exercise, rather than from muscle (alone).
This hypothesis is supported by the findings of Kitase et al.
(2018) who did not find increased levels of R-BAIBA after
contraction of isolated muscle in mice (Kitase et al., 2018). In
contrast, these investigators did find an increase of S-BAIBA in
isolated muscle.
S-BAIBA might also be acutely formed as the degradation of
valine, a BCAA and precursor of S-BAIBA (Figure 1), has been
shown to take place in muscle and liver during acute exercise
(Brosnan and Brosnan, 2006). We also observed an additional
increase of S-BAIBA following exercise suggesting that BCAA
degradation occurs during recovery. Training status might also
improve BCAA degradation capacity (Mckenzie et al., 2000;
Hatazawa et al., 2014). Indeed, we could observe a significant
positive correlation between VO2peak and both baseline
S-BAIBA and the exercise-induced increase of plasma S-BAIBA.
This correlation is not surprising as PGC-1α has been shown to
increase BAIBA in muscle (Roberts et al., 2014; Hatazawa et al.,
2015). Most likely, PGC-1α, as a transcriptional co-activator,
does not affect BAIBA levels acutely and directly, but rather
in a chronic fashion, through mitochondrial biogenesis as both
GABA-T (S-BAIBA) and AGXT2 (R-BAIBA) are mitochondrial
enzymes. Additionally, the entire valine degradation pathway
is mitochondrial which might further affect the formation of
S-BAIBA. How PGC-1α could impact thymine degradation and
therefore R-BAIBA, is unclear at this point. Altogether, the
results indicate that although the metabolite S-BAIBA is not
a peptide, it might indeed have myokine-like functions. As
CK levels, the common marker of muscle damage, remained
constant we consider it to be an active release, and not a leakage
through muscle damage.
The expression of both mitochondrial enzymes GABA-T
and AGXT2 (Figure 1), necessary to produce, respectively,
S- and R-BAIBA are quite low in muscle and high in liver.
Additionally, muscle have minimal thymine degradation activity,
but have the ability to degrade valine, while liver is able
to degrade both. Finally, Kitase et al. (2018) only found an
increase of S-BAIBA from muscle. Therefore, the liver might
be a promising target for further research with respect to
the endogenous source of BAIBA’s enantiomers by exercise.
Additionally, dipeptides containing BAIBA have been measured
in mammalian tissue (Morris et al., 1961; Kakimoto et al.,
1965) which could also be relevant to look at, especially since
the metabolically linked β-alanine is mainly stored in muscle
in conjugation with histidine (β-alanyl-L-histidine, also called
carnosine) (Boldyrev et al., 2013).
It is hard to speculate on the physiological meaning and
relevance of the observed changes in R- and S-BAIBA. Only
Kitase et al. (2018) looked at the physiological roles of
both R- and S-BAIBA separately, indicating that S-BAIBA
and not R-BAIBA is a bone-protecting factor (Kitase et al.,
2018). The 13% (R) and 20% (S) increase, measured in
the current investigation, is in the same relative range as
reported for other myokines or exerkines such as irisin [15%
(Fox et al., 2018)] and BDNF [13–30% (Ferris et al., 2007)],
but lower than for example the 100-fold changes measured
in the IL-6 (Fischer, 2006). Additionally, at baseline, these
myokines are present at similar or even lower concentrations
than S-BAIBA. This indicates that although the baseline
concentrations and the changes might be considered low,
they could be relevant. Further research needs to focus
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on the functional properties of both enantiomers. Additionally,
the determinants (e.g., training and nutritional status, exercise
intensity,.) of the release of both BAIBA enantiomers and the
minimal effective changes necessary to induce physiologically
relevant effects are unclear. Altogether, it is too early to talk about
possible paracrine or endocrine effects of BAIBA, as such.
The most important limitation of this study is the small
samples size, due to the low incidence of the TT-genotype in
Caucasians, generating a risk of false positive or negative results.
This should be taken into consideration when interpreting
the results presented in this manuscript. However, by using a
homogenous sample, matched groups and a crossover design,
together with the fact that homogenous effects were measured,
the results are certainly relevant. As the participants were
Caucasian, physically active, healthy and performed only exercise
on one intensity, generalization of results presented here warrants
caution until further confirmation.
CONCLUSION
In conclusion, this study first showed that BAIBA predominantly
consists of R-BAIBA (±98%), both in plasma and urine. Plasma
and urinary R-BAIBA, but not S-BAIBA, is markedly affected by
the AGXT2 rs37369 TT genotype underlying the hyper-BAIBA
trait. This is one of several indications that R- and S-BAIBA
have separate sources in humans. In relation to the previously
suggested role of BAIBA as a myokine, we demonstrated that
plasma levels of both R- and S-BAIBA are moderately but
significantly elevated (13–20%) by acute aerobic exercise in
humans. The physiological effects, for example in organ crosstalk
or the source tissue (myokine or exerkine) of each enantiomer
warrants further investigation.
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